Zhengye Biotechnology Holding Limited (ZYBT)

Zhengye Biotechnology Holding will go public soon, but the exact IPO date is still unknown.

IPO Price Range

$4.00 - $5.00

Shares Offered

1,250,000

Deal Size

$5.63M

ZYBT Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021
Market Capitalization	211	-	-
Enterprise Value	216	-	-
Debt / Equity Ratio	0.28	0.18	0.09
Debt / EBITDA Ratio	-	0.76	0.43
Debt / FCF Ratio	10.07	-6.49	5.55
Quick Ratio	-	0.94	0.86
Interest Coverage	-	24.45	57.82
Return on Equity (ROE)	16.04%	15.62%	14.57%
Return on Assets (ROA)	-	10.73%	10.44%
Return on Capital (ROIC)	15.06%	13.29%	12.84%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).